PubmedID,Title,Publication Date,Company Affiliation(s),Corresponding Author Email
40053902,Prospective Evaluation of the Pathologic Diagnosis and Treatment Outcomes of Pediatric Burkitt Lymphoma in the Central American Pediatric Hematology-Oncology Association Consortium.,<Year>2025</Year><Month>Mar</Month>,"<Affiliation>Department of Pediatric Oncology, Hospital Saint Damien, Port-au-Prince, Haiti.",N/A
40053901,Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country.,<Year>2025</Year><Month>Mar</Month>,"<Affiliation>Instituto Nacional do C&#xe2;ncer (INCA), Rio de Janeiro, Brazil.",N/A
40053899,Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population.,<Year>2025</Year><Month>Mar</Month>,"<Affiliation>Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.",N/A
40053891,Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group RMS 2005 Trial.,<Year>2025</Year><Month>Mar</Month><Day>07</Day>,"<Affiliation>Pathology Unit, Department of Laboratories, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy., <Affiliation>Princess M&#xe1;xima Center for Pediatric Oncology, Utrecht, the Netherlands.",N/A
